US Patent 7491400 Pharmaceutical compositions comprising attenuated HIV-1 nef-deficient viral particles
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Sateesh Apte0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+267 characters)
Article
Patent abstract
A therapeutic suspension for the treatment of human immunodeficiency virus type I (HIV-1) infection in humans using isolated and purified HIV-1 nef-deficient viral particles having a nef-deletion between the endonuclease cleavage sites Nco I and Xho I.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07491400 Pharmaceutical compositions comprising attenuated HIV-1 nef-deficient viral particles US Patent 7491400 Pharmaceutical compositions comprising attenuated HIV-1 nef-deficient viral particles
Infobox
Patent Number
074914000
Patent Number
74914000
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
074914000
Date of Patent
February 17, 2009
0Patent Application Number
108117250
Date Filed
March 29, 2004
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07491400 Pharmaceutical compositions comprising attenuated HIV-1 nef-deficient viral particles
Infobox
Is a
Patent jurisdiction
Patent number
07491400
Date of patent
February 17, 2009
Patent application number
10811725
Date Filed
March 29, 2004
Patent primary examiner
Find more entities like US Patent 7491400 Pharmaceutical compositions comprising attenuated HIV-1 nef-deficient viral particles
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
